Johns Hopkins University

Audrey Lazenby

Kam W Leong

Drew M Pardoll

Hyam I Levitsky

Elizabeth A Jaffee

Rosa V Azhari

Paul K Golumbe

Paul Golumbek

A method of stimulating a systemic immune response to a tumor cell or antigen associated with a pathogen by administering a mixture of a controlled release vehicle containing an immunopotentiating agent and antigen is described.

Controlled release of pharmaceutically active substances for immunotherapy

A method of stimulating a systemic immune response to a tumor cell or antigen associated with a pathogen by administering a mixture of a controlled release vehicle containing an immunopotentiating agent and antigen is described. The method of the invention provides sustained release of therapeutic compounds to allow a host immune system to ameliorate local as well as metastatic tumors in the host. The immunopotentiating agent is typically a cytokine such as tumor necrosis factor, GM-CSF, interleukin or interferon, for example.

Controlled release of pharmaceutically active substances for

Growing community of inventors

Baltimore, MD, United States of America

Audrey Lazenby